NO862170L - Fremstilling av quinazolinderivater. - Google Patents
Fremstilling av quinazolinderivater.Info
- Publication number
- NO862170L NO862170L NO862170A NO862170A NO862170L NO 862170 L NO862170 L NO 862170L NO 862170 A NO862170 A NO 862170A NO 862170 A NO862170 A NO 862170A NO 862170 L NO862170 L NO 862170L
- Authority
- NO
- Norway
- Prior art keywords
- group
- heteroatom
- quinazoline derivatives
- preparation
- halogeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858513754A GB8513754D0 (en) | 1985-05-31 | 1985-05-31 | Anti-cancer quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO862170L true NO862170L (no) | 1986-12-01 |
Family
ID=10579966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862170A NO862170L (no) | 1985-05-31 | 1986-05-30 | Fremstilling av quinazolinderivater. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5236927A (no) |
EP (1) | EP0204529B1 (no) |
JP (1) | JPS61282368A (no) |
AT (1) | ATE87621T1 (no) |
AU (1) | AU592271B2 (no) |
DE (1) | DE3688150T2 (no) |
DK (1) | DK255786A (no) |
ES (1) | ES8800911A1 (no) |
FI (1) | FI862303A (no) |
GB (2) | GB8513754D0 (no) |
GR (1) | GR861418B (no) |
HU (1) | HUT45512A (no) |
IL (1) | IL78910A0 (no) |
NO (1) | NO862170L (no) |
NZ (1) | NZ216363A (no) |
PT (1) | PT82682B (no) |
ZA (1) | ZA864051B (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
GB8707053D0 (en) * | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
US4857530A (en) * | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
GB8809978D0 (en) * | 1988-04-27 | 1988-06-02 | Ici Plc | Anti-tumour agents |
EP0365763A1 (en) * | 1988-09-30 | 1990-05-02 | Agouron Pharmaceuticals, Inc. | Antiproliferative cyclic compounds |
US5286726A (en) * | 1990-04-12 | 1994-02-15 | The Regents Of The University Of Michigan | Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
US6762188B1 (en) | 1990-06-19 | 2004-07-13 | Smithkline Beecham Corporation | Pharmaceutically active benzoquinazoline compounds |
GB9013615D0 (en) | 1990-06-19 | 1990-08-08 | Wellcome Found | Pharmaceutical compounds |
GB9105771D0 (en) * | 1991-03-19 | 1991-05-01 | Cancer Res Inst Royal | Anti-cancer compounds |
GB9205320D0 (en) * | 1992-03-11 | 1992-04-22 | Ici Plc | Anti-tumour compounds |
GB9205907D0 (en) * | 1992-03-18 | 1992-04-29 | Cancer Res Inst Royal | Anti-cancer compounds |
US5430148A (en) * | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
GB9223352D0 (en) * | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
US7262058B2 (en) * | 2001-03-09 | 2007-08-28 | Nonda Katopodis | Method for determining lipid associated sialoprotein in body fluids |
EP1557023A2 (en) * | 2002-10-18 | 2005-07-27 | Koninklijke Philips Electronics N.V. | Method and system for metadata protection in tv-anytime |
EP1558260A4 (en) * | 2002-11-04 | 2006-10-25 | Nps Pharma Inc | CHINAZOLINONE COMPOUNDS AS CALCILYTIC |
CN101263125A (zh) * | 2005-07-15 | 2008-09-10 | 先灵公司 | 用于癌症治疗的喹唑啉衍生物 |
US20070015774A1 (en) * | 2005-07-15 | 2007-01-18 | Schering Corporation | Quinazoline derivatives useful in cancer treatment |
KR101129868B1 (ko) | 2006-10-04 | 2012-04-12 | 화이자 프로덕츠 인코포레이티드 | 칼슘 수용체 길항제로서의 피리도[4,3-d]피리미딘-4(3H)-온 유도체 |
EP2220050A2 (en) | 2007-10-26 | 2010-08-25 | The Regents Of The University Of California | Diarylhydantoin compounds as androgen receptor modulators |
HRP20171415T4 (hr) | 2009-06-25 | 2023-03-03 | Alkermes Pharma Ireland Limited | Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja |
EP2521711B1 (en) * | 2010-01-07 | 2017-08-16 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
WO2011163594A2 (en) | 2010-06-24 | 2011-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
CN103561746B (zh) | 2011-03-18 | 2018-05-29 | 奥克梅斯制药爱尔兰有限公司 | 包含脱水山梨糖醇酯的药物组合物 |
CA2867137C (en) | 2012-03-19 | 2020-12-08 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol |
EP2827868B8 (en) | 2012-03-19 | 2019-12-18 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising fatty acid esters |
CA2867123C (en) | 2012-03-19 | 2021-02-16 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising water-insoluble antipsychotic agents and glycerol esters |
CA2885196C (en) | 2012-09-19 | 2021-06-22 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
CN110368360A (zh) | 2014-03-20 | 2019-10-25 | 奥克梅斯制药爱尔兰有限公司 | 具有增加的注射速度的阿立哌唑制剂 |
CN112423754A (zh) | 2018-03-05 | 2021-02-26 | 奥克梅斯制药爱尔兰有限公司 | 阿立哌唑的给药策略 |
WO2024028999A1 (ja) * | 2022-08-03 | 2024-02-08 | Ils株式会社 | N-[4-メチルアミノベンゾイル]-l-グルタミン酸ジエチルエステルの製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1021196A (en) * | 1964-02-20 | 1966-03-02 | Parke Davis & Co | Novel amino acids and means for producing the same |
US3471498A (en) * | 1967-08-11 | 1969-10-07 | Parke Davis & Co | Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids |
EP0031237B1 (en) * | 1979-12-19 | 1984-10-17 | National Research Development Corporation | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
-
1985
- 1985-05-31 GB GB858513754A patent/GB8513754D0/en active Pending
-
1986
- 1986-05-26 IL IL78910A patent/IL78910A0/xx unknown
- 1986-05-30 EP EP86304148A patent/EP0204529B1/en not_active Expired - Lifetime
- 1986-05-30 GB GB08613184A patent/GB2175903B/en not_active Expired
- 1986-05-30 AT AT86304148T patent/ATE87621T1/de not_active IP Right Cessation
- 1986-05-30 FI FI862303A patent/FI862303A/fi not_active Application Discontinuation
- 1986-05-30 JP JP61125587A patent/JPS61282368A/ja active Pending
- 1986-05-30 ZA ZA864051A patent/ZA864051B/xx unknown
- 1986-05-30 HU HU862288A patent/HUT45512A/hu unknown
- 1986-05-30 AU AU58220/86A patent/AU592271B2/en not_active Ceased
- 1986-05-30 PT PT82682A patent/PT82682B/pt not_active IP Right Cessation
- 1986-05-30 NO NO862170A patent/NO862170L/no unknown
- 1986-05-30 DK DK255786A patent/DK255786A/da not_active Application Discontinuation
- 1986-05-30 DE DE8686304148T patent/DE3688150T2/de not_active Expired - Fee Related
- 1986-05-30 ES ES555548A patent/ES8800911A1/es not_active Expired
- 1986-05-30 NZ NZ216363A patent/NZ216363A/xx unknown
- 1986-05-30 GR GR861418A patent/GR861418B/el unknown
-
1990
- 1990-12-12 US US07/625,695 patent/US5236927A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0204529A2 (en) | 1986-12-10 |
ES8800911A1 (es) | 1987-12-01 |
US5236927A (en) | 1993-08-17 |
PT82682B (pt) | 1988-03-03 |
ES555548A0 (es) | 1987-12-01 |
IL78910A0 (en) | 1986-09-30 |
PT82682A (en) | 1986-06-01 |
HUT45512A (en) | 1988-07-28 |
FI862303A0 (fi) | 1986-05-30 |
GB2175903A (en) | 1986-12-10 |
EP0204529B1 (en) | 1993-03-31 |
FI862303A (fi) | 1986-12-01 |
AU5822086A (en) | 1986-12-04 |
DE3688150T2 (de) | 1993-07-29 |
DK255786D0 (da) | 1986-05-30 |
DE3688150D1 (de) | 1993-05-06 |
DK255786A (da) | 1986-12-01 |
NZ216363A (en) | 1989-07-27 |
AU592271B2 (en) | 1990-01-04 |
ATE87621T1 (de) | 1993-04-15 |
GR861418B (en) | 1986-09-26 |
GB2175903B (en) | 1988-10-12 |
EP0204529A3 (en) | 1987-11-19 |
GB8513754D0 (en) | 1985-07-03 |
GB8613184D0 (en) | 1986-07-02 |
ZA864051B (en) | 1987-01-28 |
JPS61282368A (ja) | 1986-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO862170L (no) | Fremstilling av quinazolinderivater. | |
MX166257B (es) | Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo | |
DE3784501D1 (de) | Wasserabweisendes mittel fuer bauwerke. | |
DK345989D0 (da) | Quinolinderivater | |
DE3772015D1 (de) | Chinolinverbindung. | |
SE8302694L (sv) | Immunomudulerande medel | |
AR247744A1 (es) | Compuestos organosilano y catalizadores que contienen dichos compuestos | |
ES2055384T3 (es) | Compuestos dioxafosforinanos y composiciones poliolefinicas estabilizadas con ellos. | |
MX170732B (es) | Composicion de derivados de succinimida y su uso | |
DE3661198D1 (en) | Phosphate ester derivatives, and their use as anti-cancer agents | |
ATE142620T1 (de) | 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität | |
DE3688128D1 (de) | Isoindolinderivate und verfahren zu ihrer herstellung. | |
NO863647D0 (no) | Propanolderivater. |